A/Prof Gemma Kelly
Honorary (Principal Fellow)
Department of Medical Biology (WEHI)
71 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
MNT: a new target for AML
DOI: 10.1016/j.bneo.2025.1001492025
Journal article
Awakening the Genome: CRISPR Activation to Unravel the Origin and Vulnerabilities of Cancer
DOI: 10.1146/annurev-cancerbio-062624-1041492025
Journal article
Characterizing and Targeting of BCL-2 Family Members in Nasopharyngeal Carcinoma
DOI: 10.1002/hed.279732025
Journal article
Breathing new insights into the role of mutant p53 in lung cancer
DOI: 10.1038/s41388-024-03219-62021
Journal article
Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias
DOI: 10.1182/blood.20200101672018
Journal article
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
DOI: 10.1016/j.ccell.2018.11.0042016
Journal article
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
DOI: 10.1038/nature19830
RECENT SCHOLARLY WORKS
2025
Journal article
Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphoma
DOI: 10.1038/s41467-025-62615-y2024
Journal article
Genome-scale clustered regularly interspaced short palindromic repeats screen identifies nucleotide metabolism as an actionable therapeutic vulnerability in diffuse large B-cell lymphoma
DOI: 10.3324/haematol.2023.2844042024
Journal article
Don't fear the reaper: The role of regulated cell death in tumorigenesis and BH3-mimetics for cancer therapy
DOI: 10.1016/j.devcel.2024.06.0182024
Journal article
Mouse models to investigate in situ cell fate decisions induced by p53
DOI: 10.1038/s44318-024-00189-z2024
Journal article
Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers
DOI: 10.1016/j.ccell.2024.04.0042024
Journal article
Cancer Hallmarks: Piecing the Puzzle Together
DOI: 10.1158/2159-8290.CD-24-0097